As melanoma cells overexpress membrane-bound melanocortin type 1 receptors (MC1Rs) (3–5), suitable ligands for MC1R are candidates for targeting melanoma with diagnostic or therapeutic radioisotopes (6) or toxin conjugates (7). Here, MC1R is linked to melanoma.